ANTONELLA DE PALMA

Dr. ANTONELLA DE PALMA

National Research Council (CNR), Institute for Biomedical Technologies
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
Barbara MolonBarbara Molon
Barbara Molon
SUStefano Ugel
Stefano Ugel
FPFederica Del Pozzo
Federica Del Pozzo
CScristiana soldani
cristiana soldani
SZSerena Zilio
Serena Zilio
AVAntonella Viola
Antonella Viola
Tumor-promoted constraints negatively affect cytotoxic T lymphocyte (CTL) trafficking to the tumor core and, as a result, inhibit tumor killing. The production of reactive nitrogen species (RNS) within the tumor microenvironment has been reported in mouse and human cancers. We describe a novel RNS-dependent posttranslational modification of chemokines that has a profound impact on leukocyte recruitment to mouse and human tumors. Intratumoral RNS production induces CCL2 chemokine nitration and hinders T cell infiltration, resulting in the trapping of tumor-specific T cells in the stroma that surrounds cancer cells. Preconditioning of the tumor microenvironment with novel drugs that inhibit CCL2 modification facilitates CTL invasion of the tumor, suggesting that these drugs may be effective in cancer immunotherapy. Our results unveil an unexpected mechanism of tumor evasion and introduce new avenues for cancer immunotherapy.

5 June 2018 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
FZFabio A. Zucca
Fabio A. Zucca
RVRenzo Vanna
Renzo Vanna
FCFrancesca Anna Cupaioli
Francesca Anna Cupaioli
CBChiara Bellei
Chiara Bellei
ANTONELLA DE PALMAANTONELLA DE PALMA
ANTONELLA DE PALMA
LZLuigi Zecca
Luigi Zecca
During aging, neuronal organelles filled with neuromelanin (a dark-brown pigment) and lipid bodies accumulate in the brain, particularly in the substantia nigra, a region targeted in Parkinson’s disease. We have investigated protein and lipid systems involved in the formation of these organelles and in the synthesis of the neuromelanin of human substantia nigra. Membrane and matrix proteins characteristic of lysosomes were found in neuromelanin-containing organelles at a lower number than in typical lysosomes, indicating a reduced enzymatic activity and likely impaired capacity for lysosomal and autophagosomal fusion. The presence of proteins involved in lipid transport may explain the accumulation of lipid bodies in the organelle and the lipid component in neuromelanin structure. The major lipids observed in lipid bodies of the organelle are dolichols with lower amounts of other lipids. Proteins of aggregation and degradation pathways were present, suggesting a role for accumulation by this organelle when the ubiquitin-proteasome system is inadequate. The presence of proteins associated with aging and storage diseases may reflect impaired autophagic degradation or impaired function of lysosomal enzymes. The identification of typical autophagy proteins and double membranes demonstrates the organelle’s autophagic nature and indicates that it has engulfed neuromelanin precursors from the cytosol. Based on these data, it appears that the neuromelanin-containing organelle has a very slow turnover during the life of a neuron and represents an intracellular compartment of final destination for numerous molecules not degraded by other systems.

1 October 2015 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Laura OrianLaura Orian
Laura Orian
PIETROLUIGI MAURIPIETROLUIGI MAURI
PIETROLUIGI MAURI
Antonella RoveriAntonella Roveri
Antonella Roveri
STStefano Toppo
Stefano Toppo
LBLouise Benazzi
Louise Benazzi
FUFulvio Ursini
Fulvio Ursini

1 January 2007 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MMMatilde Maiorino
Matilde Maiorino
FUFulvio Ursini
Fulvio Ursini
Valentina Bosello TravainValentina Bosello Travain
Valentina Bosello Travain
STStefano Toppo
Stefano Toppo
STSilvio Tosatto
Silvio Tosatto
LFLeopold Flohé
Leopold Flohé

24 March 2021 in Mass Spectrometry Reviews
Verified
Journal Article
Open access
PDF file
Erika PonziniErika Ponzini
Erika Ponzini
CSCarlo Santambrogio
Carlo Santambrogio
ANTONELLA DE PALMAANTONELLA DE PALMA
ANTONELLA DE PALMA
PMPierluigi Mauri
Pierluigi Mauri
STSilvia Tavazzi
Silvia Tavazzi
RGRita Grandori
Rita Grandori
The lacrimal film has attracted increasing interest in the last decades as a potential source of biomarkers of physiopathological states, due to its accessibility, moderate complexity, and responsiveness to ocular and systemic diseases. High‐performance liquid chromatography‐mass spectrometry (LC‐MS) has led to effective approaches to tear proteomics, despite the intrinsic limitations in sample amounts. This review focuses on the recent progress in strategy and technology, with an emphasis on the potential for personalized medicine. After an introduction on lacrimal‐film composition, examples of applications to biomarker discovery are discussed, comparing approaches based on pooled‐sample and single‐tear analysis. Then, the most critical steps of the experimental pipeline, that is, tear collection, sample fractionation, and LC‐MS implementation, are discussed with reference to proteome‐coverage optimization. Advantages and challenges of the alternative procedures are highlighted. Despite the still limited number of studies, tear quantitative proteomics, including single‐tear investigation, could offer unique contributions to the identification of low‐invasiveness, sustained‐accessibility biomarkers, and to the development of personalized approaches to therapy and diagnosis.

4 March 2005 in Journal of Proteome Research
Verified
Journal Article
Closed access
ECEnrica Calleri
Enrica Calleri
CTCaterina Temporini
Caterina Temporini
EPEleonora Perani
Eleonora Perani
ANTONELLA DE PALMAANTONELLA DE PALMA
ANTONELLA DE PALMA
DLDieter Lubda
Dieter Lubda
GMGabriella Massolini
Gabriella Massolini